Rhythm Pharmaceuticals, Inc. RYTM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s invested capital?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported invested capital of $173.08M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s invested capital increased by 554.6% year-over-year, from $26.44M to $173.08M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s invested capital has grown at a 22.5% compound annual growth rate (CAGR), from $71.31M to $196.94M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).